Recruiting Lung Cancer Studies in Guangzhou
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
This clinical trial is designed to assess the efficacy and safety of trastuzumab deruxtecan (T-DXd; Enhertu®) in combination with pembrolizumab versus platinum-based chemotherapy in combination with p...
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
First-in-human, Phase I/II, Multicenter, Open-Label Study of EMB-01 in Patients with Advanced/Metastatic Solid Tumors...
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
Indication:Patients with Advanced c-MET-positive Non-Small Cell Lung Cancer Phase Ib (China only): Approximately 90 patients Phase â…¡ (globally): Approximately 78 evaluable patients; addition of at...
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
Researchers are looking for new ways to treat non-small cell lung cancer (NSCLC) that is metastatic, which means cancer has spread to other parts of the body. Some people with metastatic NSCLC are tr...
About Lung Cancer Clinical Trials in Guangzhou
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 4 lung cancer clinical trials recruiting participants in Guangzhou, GUANGDONG. These studies are seeking a combined 1,215 participants. Research is being sponsored by Daiichi Sankyo, Shanghai EpimAb Biotherapeutics Co., Ltd., Haihe Biopharma Co., Ltd. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Guangzhou — FAQ
Are there lung cancer clinical trials in Guangzhou?
Yes, there are 4 lung cancer clinical trials currently recruiting in Guangzhou, GUANGDONG. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Guangzhou?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Guangzhou research site will contact you about next steps.
Are clinical trials in Guangzhou free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Guangzhou studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 4 active trials in Guangzhou are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov